Blisovi 24 Fe Kit
Product Images NDC 68180-864

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Blisovi 24 Fe (NDC 68180-864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A5f436c4 Fc5d 4c8f B383 D0e6d3a55347 01

A forest plot showing effect estimates (odds ratios/relative risks) with confidence intervals from various studies related to contraceptive use, including NICH Women's Contraceptive Study, French E3N cohort, Shangai Women’s Health Study, Nurses’ Health Study II, Oxford Family Planning Association, and Danish Sex Hormone Register Study. Comparisons include ever and current use with effect sizes ranging approximately from 0.8 to 1.7.*

FDA Label Image

A5f436c4 Fc5d 4c8f B383 D0e6d3a55347 02

Chemical structure of the active ingredient associated with Blisovi 24 Fe, illustrating a steroid-like molecular framework with hydroxyl groups and a triple bond.*

FDA Label Image

A5f436c4 Fc5d 4c8f B383 D0e6d3a55347 03

Chemical structure diagram of the active ingredient in Blisovi 24 Fe, depicting a steroidal backbone with multiple rings and functional groups including a ketone and ester moieties.*

FDA Label Image

A5f436c4 Fc5d 4c8f B383 D0e6d3a55347 04

A pharmacokinetic line graph showing norethindrone concentration (pg/mL) over time (hours) on Day 1 and Day 24. Day 1 is represented by a solid line with filled circles, and Day 24 by a dotted line with open circles, illustrating concentration changes over 60 hours.*

FDA Label Image

A5f436c4 Fc5d 4c8f B383 D0e6d3a55347 05

A pharmacokinetic curve showing ethinyl estradiol concentration (pg/mL) in blood plasma over time (hours) on Day 1 and Day 24. The chart compares the concentration profiles, indicating initial peak values and subsequent decline over a 60-hour period for Blisovi 24 Fe.*

FDA Label Image

A5f436c4 Fc5d 4c8f B383 D0e6d3a55347 06

A chart depicting pregnancy rates per 100 women in one year relative to birth control methods. It categorizes contraceptive methods from fewer to more pregnancies, listing implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, spermicides, withdrawal, and no birth control.*

FDA Label Image

A5f436c4 Fc5d 4c8f B383 D0e6d3a55347 07

An instructional diagram showing a 4-week weekly pop-out pill pack tracker labeled with days of the week (Sunday to Saturday) and numbered weeks from 1 to 4. It includes instructions for starting the medication on day 1 of the menstrual period with arrows indicating the sequence of pill intake. A reminder for a monthly self-breast exam is noted to the right side of the diagram.*

FDA Label Image

A5f436c4 Fc5d 4c8f B383 D0e6d3a55347 08

Blisovi 24 Fe 1 mg/0.02 mg tablet foil blister packaging label showing the imprint of norethindrone acetate, ethinyl estradiol, and ferrous fumarate. It includes storage instructions at 25°C, manufacturer Lupin Limited in India, and distributor Lupin Pharmaceuticals, Inc. The label displays a 28-day dosing calendar with daily circles for tablet placement and a barcode with NDC 68180-864-71.*

FDA Label Image

A5f436c4 Fc5d 4c8f B383 D0e6d3a55347 09

Blisovi 24 Fe 1 mg/0.02 mg tablets packaging label from Lupin Pharmaceuticals, Inc. The label indicates the product contains norethindrone acetate, ethinyl estradiol tablets USP, and ferrous fumarate tablets. It specifies one blister pack of 28 tablets providing 24 days of active therapy. The label includes an NDC number 68180-864-71 and additional regulatory and usage information.*

FDA Label Image

A5f436c4 Fc5d 4c8f B383 D0e6d3a55347 10

Packaging label for Blisovi 24 Fe, tablets containing 1 mg norethindrone acetate and 0.02 mg ethinyl estradiol with ferrous fumarate tablets. Label shows the product name, active ingredients, dosage strengths, Rx only designation, manufacturer Lupin Pharmaceuticals, Inc., and includes two barcodes, NDC 68180-864-73, and usage information stating the product provides 24 days of active therapy.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.